| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 790702-57-7 | ML414(NGI-1) |
≥98% | | 询价 |
| 2 | 2031161-35-8 | UT-155 |
≥98% | | 询价 |
| 3 | 1807523-99-4 | IACS-010759 HCl |
≥98% | | 询价 |
| 4 | 1570496-34-2 | IACS-10759 |
≥98% | | 询价 |
| 5 | 1430806-04-4 | PF-05089771 Tosylate |
≥98% | | 询价 |
| 6 | | ND-630 S enantiomer |
≥98% | | 询价 |
| 7 | 16676-29-2 | Naltrexone HCl |
≥98% | | 询价 |
| 8 | 873436-91-0 | PU-H71 |
≥98% | | 询价 |
| 9 | 357-08-4 | Naloxone HCl |
≥98% | | 询价 |
| 10 | 1207989-22-7 | LGD-6972 sodium |
≥98% | | 询价 |
| 11 | 1041434-82-5 | Peramivir Trihydrate(RWJ-270201 BCX-1812) |
≥98% | | 询价 |
| 12 | 1222513-26-9 | CID 44216842 |
≥98% | | 询价 |
| 13 | 2222094-18-8 | BC1618 |
≥98% | | 询价 |
| 14 | 103926-82-5 | Sepimostate mesilate |
≥98% | | 询价 |
| 15 | 1227098-15-8 | NF-κB-IN-1 |
≥98% | | 询价 |
| 16 | 292168-90-2 | IT-603 |
≥98% | | 询价 |
| 17 | 2229025-70-9 | WM 3835 |
≥98% | | 询价 |
| 18 | 19356-17-3 | Calcifediol(25-hydroxy Vitamin D3) |
≥98% | | 询价 |
| 19 | 1127442-87-8 | exo-IWR-1 |
≥98% | | 询价 |
| 20 | 1201652-50-7 | Retro 2 |
≥98% | | 询价 |
| 21 | 2374285-52-4 | CEBPαinducer 1 |
≥98% | | 询价 |
| 22 | 1683535-53-6 | Apcin A HCL |
≥98% | | 询价 |
| 23 | 313480-47-6 | IGS-1,76 |
≥98% | | 询价 |
| 24 | 349093-44-3 | PTGR2-IN-1 |
≥98% | | 询价 |
| 25 | 1247000-76-5 | CFI-400437 HCl |
≥98% | | 询价 |
| 26 | 2243944-92-3 | FTO-IN-1 |
≥98% | | 询价 |
| 27 | 745-65-3 | Alprostadil(PGE1 Prostaglandin-E1) |
≥98% | | 询价 |
| 28 | 858557-69-4 | 26S proteasome inhibitor I |
≥98% | | 询价 |
| 29 | 481-53-8 | Tangeretin(Tangeritin NSC53909) |
≥98% | | 询价 |
| 30 | 79595-97-4 | Norbergenin |
≥98% | | 询价 |
| 31 | 179246-08-3 | GW 284543 hydrochloride |
≥98% | | 询价 |
| 32 | 2060530-16-5 | K-Ras inhibitor 6 |
≥98% | | 询价 |
| 33 | 423735-93-7 | ML161(Parmodulin 2) |
≥98% | | 询价 |
| 34 | 148465-45-6 | Crofelemer(Mytesi,Fulyzaq) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 72573-82-1 | Gadoteric acid(DOTA-Gd,gadoterate meglumine Artirem Dotarem Clariscan) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | | DS-1594 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | | KO-539 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 2363165-42-6 | M-89 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 2134169-43-8 | MI-3454 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 2387510-80-5 | MRK-740 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 2247890-13-5 | BAY-6035 |
≥98% | | 询价 |
| 42 | | SGC8158 |
≥98% | | 询价 |
| 43 | 2569009-58-9 | PF-9363(CTX-648) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 423731-64-0 | CTX-012414 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 2379416-47-2 | B026(SYY-B085-1) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 765922-62-1 | Flutemetamol F18(Vizamyl) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 186018-45-1 | Metreleptin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 902143-01-5 | Florbetaben F18(BAY-949172 NeuraCeq) |
≥98% | | 询价 |
| 49 | | Compound 6q |
≥98% | | 询价 |
| 50 | | Ainuovirine |
≥98% | | 询价 |
| 51 | | Hybutimibe |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 1571076-26-0 | Tenofovir amibufenamide(HS-10234) |
≥98% | | 询价 |
| 53 | 99896-86-3 | H-Gly-Arg-Ala-Asp-Ser-Pro-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 125455-58-5 | H-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 125455-56-3 | (Tyr15)-Fibrinopeptide B |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 103213-49-6 | (Glu1)-Fibrinopeptide B |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | | (Tyr0)-Fibrinopeptide A |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 149836-35-1 | H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 126047-75-4 | H-Gly-Pro-Arg-Pro-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 47295-77-2 | H-Gly-Pro-Arg-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com